This agreement includes upfront and milestone payments with a combined potential value of over $500m and sales royalties.
Liraglutide belongs to the class of glucagon like peptide 1 receptor agonist (GLP?1 RA) drugs
10+ emerging markets, Japan & ANZ transition in final phase
The company makes its maiden entry into Azerbaijan’s pharmaceutical market
Submissions based on positive data from the Phase 3 BASIS trial, which were presented this past weekend at the American Society of Hematology (ASH) Annual Meeting
The findings of Phase 3 study are in line with Phase 2 study conducted in the US and Europe
The CVMP recommends the product for approval for the treatment and persistent killing of fleas
Dr. Reddy's will make a US$ 7.5 million upfront payment to Coya
The full transition of Viatris' biosimilars operations to Biocon Biologics in Europe represents another significant milestone
South Asia’s largest Trade Fair for pharma brought together over 50,000 visitors from across the globe, more than 1,500 exhibitors showcasing 10,000+ products and representation from over 80 countries
Subscribe To Our Newsletter & Stay Updated
